Published in Exp Neurol on October 20, 2016
The incidence of complex regional pain syndrome: a population-based study. Pain (2006) 3.20
Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med (2010) 2.55
Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain (2011) 1.89
Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci U S A (2013) 1.16
A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome. Pain (2013) 1.09
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain (2010) 1.09
Local Joint Inflammation and Histone Citrullination in a Murine Model of the Transition From Preclinical Autoimmunity to Inflammatory Arthritis. Arthritis Rheumatol (2015) 1.02
Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE. Front Immunol (2016) 0.91
Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain (2009) 0.91
Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain (2014) 0.90
Aberrant B cell selection and activation in systemic lupus erythematosus. Int Rev Immunol (2013) 0.88
Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells. Clin Exp Immunol (2015) 0.85
Trichohyalin is a potential major autoantigen in human alopecia areata. J Proteome Res (2010) 0.83
The inauguration of Cytokine & Growth Factor Reviews. Cytokine Growth Factor Rev (1996) 0.80
New Concepts in Complex Regional Pain Syndrome. Hand Clin (2016) 0.80
Activation of cutaneous immune responses in complex regional pain syndrome. J Pain (2014) 0.90